Dzerve Vilnis, Lejnieks Aivars
Latvian Institute of Cardiology, Riga, Latvia.
Blood Press Suppl. 2005 Dec;2:29-32. doi: 10.1080/08038020500428690.
The aims of investigations were to assess the prevalence of arterial hypertension (AH) among Latvian population aged > or = 45 years and to evaluate the current AH management situation in Latvia. Four epidemiological databases (Dbases) for analyses were selected: Dbases of a randomized urban population of Riga city (in 1997) and Kuldiga region (in 2000), a Dbase of the DIASCREEN population selected by high risk to diabetes from those visiting family doctors (in 2003) and a Dbase of a Latvian population selected from those visiting family doctors during 3 days in 2005. The prevalence of AH in the urban population was 41.8 +/- 1.4% (with 61.2% for persons over age 45), in rural population 40.5 +/- 1.6% (with 63.7% for those aged above 45). Therapeutic control of AH for patients over 45 years with regular medicine intake differed significantly in three samples of the population analysed: Riga 7.2 +/- 2.7%, Kuldiga 9.9 +/- 1.6% and DIASCREEN 6.4 +/- 0.8%. The addition of another risk factor decreases the control rate, especially in a combination of AH and overweight. The most widely prescribed drugs are angiotensin-converting enzyme inhibitors (ACEI) 31%, diuretics 21% and beta-blockers 20% of patients. AH control rate in the case of monotherapy with ACEI was 6.9 +/- 0.9%, calcium antagonists 5.6+1.2%, beta-blockers 12.5+2.0% and diuretics 3.8+1.4%. The current status of management of hypertension in Latvia is discussed.
调查目的是评估拉脱维亚45岁及以上人群中动脉高血压(AH)的患病率,并评估拉脱维亚目前的AH管理状况。选择了四个用于分析的流行病学数据库:里加市随机城市人口数据库(1997年)和库尔迪加地区数据库(2000年)、从看家庭医生的人群中按糖尿病高风险选择的DIASCREEN人群数据库(2003年)以及2005年3天内从看家庭医生的人群中选择的拉脱维亚人群数据库。城市人口中AH的患病率为41.8±1.4%(45岁以上人群为61.2%),农村人口中为40.5±1.6%(45岁以上人群为63.7%)。在分析的三个样本人群中,45岁以上定期服药患者的AH治疗控制率有显著差异:里加为7.2±2.7%,库尔迪加为9.9±1.6%,DIASCREEN为6.4±0.8%。增加另一个风险因素会降低控制率,尤其是AH与超重同时存在时。最常处方的药物是血管紧张素转换酶抑制剂(ACEI),占患者的31%;利尿剂占21%;β受体阻滞剂占20%。ACEI单药治疗时的AH控制率为6.9±0.9%,钙拮抗剂为5.6+1.2%,β受体阻滞剂为12.5+2.0%,利尿剂为3.8+1.4%。文中讨论了拉脱维亚高血压管理的现状。